Itch as the major mediator of the effect of tofacitinib on health-related quality of life in PSA: a mediation analysis by Taylor, P, Bushmakin, AG, Cappelleri, JC, Young, P, Germino, R, Merola, JF, Yosipovitch, G

Itch as major mediator of effect of tofacitinib on health-related quality of life in psoriatic arthritis: a mediation analysis by Taylor, PC, Bushmakin, AG, Cappelleri, JC, Young, P, Germino, R, Merola, JF, Yosipovitch, G

Relationships of dermatologic symptoms and quality of life in patients with psoriatic arthritis: analysis of two tofacitinib phase III studies by Taylor, P, Bushmakin, AG, Cappelleri, JC, Young, P, Germino, R, Merola, JF, Yosipovitch, G

Time to response for clinical and patient-reported outcomes in patients with psoriatic arthritis treated with tofacitinib, adalimumab, or placebo by Gladman, DD, Coates, LC, Wu, J, Fallon, L, Bacci, ED, Cappelleri, JC, Bushmakin, AG, Helliwell, PS

Relationships between psoriatic arthritis composite measures of disease activity with patient-reported outcomes in Phase 3 studies of tofacitinib by Coates, L, Bushmakin, AG, FitzGerald, O, Gladman, DD, Fallon, L, Cappelleri, JC, Hsu, MA, Helliwell, PS

Pain and inflammation as mediators of tofacitinib treatment effect on fatigue in patients with ankylosing spondylitis: a mediation analysis by Kristensen, LE, Navarro-Compán, V, Magrey, M, Bushmakin, AG, Cappelleri, JC, Yndestad, A, Dina, O, Taylor, PC

Identifying mediators of pain reduction in patients with psoriatic arthritis treated with tofacitinib: Role of inflammation associated with peripheral arthritis, enthesitis and ski... by Taylor, PC, De Vlam, K, Bushmakin, AG, Fallon, L, Merola, JF, Cappelleri, JC, Hsu, MA, Mease, PJ

Multimodal Treatment Patterns for Osteoarthritis and Their Relationship to Patient-Reported Pain Severity: A Cross-Sectional Survey in the United States by Nalamachu SR, Robinson RL, Viktrup L, Cappelleri JC, Bushmakin AG, Tive L, Mellor J, Hatchell N, Jackson J

Get full text

Median time to pain improvement and the impact of baseline pain severity on pain response in patients with psoriatic arthritis treated with tofacitinib by de Vlam, K, Ogdie, A, Bushmakin, AG, Cappelleri, JC, Fleischmann, R, Taylor, PC, Azevedo, V, Fallon, L, Woolcott, J, Mease, PJ

Identifying and quantifying the role of inflammation in pain reduction for patients with psoriatic arthritis treated with tofacitinib: a mediation analysis by de Vlam, K, Mease, PJ, Bushmakin, AG, Fleischmann, R, Ogdie, A, Azevedo, VF, Merola, JF, Woolcott, J, Cappelleri, JC, Fallon, L, Taylor, PC